Searchable abstracts of presentations at key conferences in endocrinology

ea0011p91 | Clinical case reports | ECE2006

Aortic involvement in Turner syndrome

Ilyas M , Atkin SL , Mathew V , Chu C , Ettles D

Background: Turner syndrome has well recognised cardiovascular complications that appear in up to 40% of the patients and are more common in monosomy X. Left sided obstructive lesions are relatively more frequent and predispose to aortic root dilatation and life threatening aortic dissection. Patients with bicuspid aortic valve, hypertension, coarctation and aortic stenosis are at high risk of aortic dilatation and dissection. Various follow up strategies are in use but there ...

ea0063mte8 | (1) | ECE2019

Comorbidities in Turner Syndrome

Gravholt Claus H.

Treatment with growth hormone (GH) during childhood and adolescence allows a considerable gain in adult height. SHOX deficiency explains some of the phenotypic characteristics in TS, principally short stature. Puberty has to be induced in most cases, and female sex hormone replacement therapy should continue during adult years. These issues are normally dealt with by the paediatrician, but once a TS female enters adulthood it is less clear who should be the primary care giver....

ea0032s13.2 | Hormonal treatment in transition of patients with rare diseases (Supported by the <ulink url="http://www.eje-online.org/"><emphasis role="italic">European Journal of Endocrinology</emphasis></ulink>) | ECE2013

Transition of females with Turner syndrome

Gravholt Claus H

Treatment with GH during childhood and adolescence allows a considerable gain in adult height. SHOX deficiency explains some of the phenotypic characteristics in TS, principally short stature. Puberty has to be induced in most cases, and female sex hormone replacement therapy should continue during adult years. These issues are normally dealt with by the paediatrician, but once a TS female enters adulthood it is less clear who should be the primary care giver. Morbidity and mo...

ea0007p108 | Endocrine tumours and neoplasia | BES2004

Systemetic dose extension of octreotide LAR - the importance of individual tailoring of treatment

Thornton-Jones V , Wass J , Turner H

VA Thornton-Jones, JAH Wass and HE Turner, OBJECTIVE: Despite a recommended injection frequency of 4 weekly(4w), prolonged duration of GH suppression has been observed in some patients following treatment with long-acting somatostatin analogues. The aim of our study was to perform a prospective systematic study to determine whether extending the interval between doses of Octreotide LAR (LAR) allows maintenance of 'safe' GH in selected patients with acromegaly.<p class="abs...

ea0003p137 | Endocrine Tumours and Neoplasia | BES2002

Do non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than other non-functioning adenomas?

Bradley K , Turner H , Wass J

Background: Anecdotal reports have suggested that silent ACTH tumours behave in an aggressive fashion, however, clear comparative data are lacking.Methods: 28 patients (16 men, mean age 51.3years [range 30-80years]) who underwent trans-sphenoidal surgery in Oxford between 1975 and 2001 for clinically non-functioning adenomas where the subsequent immunostaining was positive for ACTH were identified from the patient database. The mean follow-up period was...

ea0029p1006 | Growth hormone IGF axis - basic | ICEECE2012

Association Turner's syndrome and GH deficiency

Oueslati I. , Hadj Ali I. , Khiari K. , Mchirgui N. , Ben Abdallah N.

One of the most clinical characteristic of Turner’s syndrome is the final short stature.In order to cure this handicap, several teams were interested to treat these patients by the GH.We report two cases of Turner syndrome associated with GH deficiency.In the first, a 17 years old girl, having a delayed growth lower than −4 S.D. associated with delayed puberty and dysmorphic syndrome...

ea0090p466 | Reproductive and Developmental Endocrinology | ECE2023

Hyperprolactinemia in Turner syndrome

Haj Kacem Akid Faten , Trimeche Oumeyma , Mnif Mouna , Hamdi Frikha , Ben Salah Dhoha , Elleuch Mouna , Fatma Mnif , Charfi Nadia , Rekik Majdoub Nabila , Abid Mohamed

Introduction: Hyperprolactinemia is a relatively frequent finding. A wide range of conditions can be responsible of this biochemical abnormality. Herein we report a rather rare etiology of hyperprolactinemia which is Turner syndrome (TS).Methods: Aiming to determine the frequency of hyperprolactinemia in patients with TS, we enrolled a retrospective descriptive study in the department of Endocrinology at the Hedi Chaker Hospital. We included patients who...

ea0073aep601 | Reproductive and Developmental Endocrinology | ECE2021

Hearing abnormalities in Turner patients

Bouichrat Nisrine , Najoua Messaoudi , Karrou Marouan , Mahroug Ikram , Rouf Siham , Latrech Hanane

IntroductionTurner Syndrome is a relatively rare genetic disorder related to the total or partial absence of an X chromosome. Its clinical presentation is very heterogeneous. It can be associated with several organic abnormalities, including hearing disorders. The objective of our work is to study the prevalence of otologic abnormalities in our Turner patients.Material and methodThis is a retrospective descri...

ea0002sp24 | A Legacy from Birth: a Focus on Turner's and Kallmanns | SFE2001

Being Different - The Challenges for Turner Girls

King S

Being different = XOTurner Syndrome is a chromosomal abnormality where all or part of one X chromosome is missing causing some or all of the body cells to have one inactive, an absent or only a fragment of one X chromosome. Physical manifestation of the classic features of Turner Syndrome are well described, what is not so well understood are the psychosocial aspects of Turner Syndrome.Although intelligence is generally in the norm...

ea0082wb5 | Workshop B: Disorders of growth and development | SFEEU2022

A rare case of Turner’s syndrome

Thant Aye Aye , Majeed Waseem

Introduction: Primary amenorrhea is usually caused by either gonadal or anatomical abnormalities. Turner’s syndrome (TS) is the result of partial or complete absence of X chromosome in females with an incidence of 1 in 2500 live female births. Mullerian agenesis due to Mayer-Rokitansky-Hauser syndrome (M-R-K-H syndrome; embryonic underdevelopment of the vagina with variable uterine development) has an incidence of 1 in 5000 females and can be mistakenly diagnosed in patie...